Study wrapper · #880
Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.
Mosqueira A, Ansarifar S, Nabavi S, et al. Molecular brain. 2026.
DOI: 10.1186/s13041-026-01329-8PubMed: 42436546
Editor's note
A mechanistic mouse study showing semaglutide shifts behavior and nucleus accumbens oscillations even in healthy, non-diseased animals. As a single small animal study it is early-stage and does not translate directly to humans, but it is genuinely about semaglutide and adds to the growing interest in its central-nervous-system effects. Frame it as preclinical signal, not clinical evidence.
Plain-language abstract
In healthy mice, daily semaglutide altered stress- and reward-related behaviors and changed electrical activity in a brain reward region. The authors present this as a baseline for understanding the drug's broader brain effects.
Related coverage
Weak / none
A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'.
Scandinavian journal of primary health caren=——2026
Mixed
GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.
Annals of medicinen=——2026
Weak / none
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Journal of medical economicsn=——2026